498-499 / 1778
GOG-122
Randall et al, JCO 2006
N=396, stage III-IV(residual)
Chemotherapy (doxorubicin-cisplatin x8) vs whole abdominal RT (WAI)
Adjusted 5-yr OS: 53 vs 42% for chemo vs WAI
Event rates similar: 54 vs 50%
Substantial toxicity in chemotherapy arm
Progression-free Survival
Overall Survival
Salvage by RT?